New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

21

Shaheed Peera Joins FCB Health Europe as Global Creative Partner 

IPG Health CEO Dana Maiman announced that Shaheed Peera joined FCB Health Europe as Global Creative Partner. Best known as founder of the Creative Floor Awards, in addition to other countless achievements, Peera will partner with creative leaders, championing collaboration, diversity & inclusion and continued unparalleled creative excellence across the FCB Health family of agencies.

23

Sanofi Shutters Principia’s San Francisco Labs After BTK Failure

According to a California WARN notice, Sanofi is shuttering Principia Biopharma’s laboratories in San Francisco and laying off about three dozen employees after the Phase III PEGASUS trial failure of rilzabrutinib for pemphigus.

24

Merck and Otsuka Recognized for Driving Greater Equality for Women in the Workplace by Healthcare Businesswomen’s Association

With gender inequality a continued area of focus for corporations and workplaces around the globe, the Healthcare Businesswomen’s Association (HBA) recognized Merck & Co. Inc. and Otsuka America Pharmaceutical Inc. for exemplary workplace initiatives working to close the gender gap in the healthcare and life science industries.

25

U.S. buys additional doses of Eli Lilly, Regeneron COVID-19 therapy

Eli Lilly said on Sept. 15 the U.S. government bought 388,000 additional doses of the company’s Covid-19 antibody therapy and Regeneron Pharmaceuticals said on Sept. 14 the U.S. government was buying 1.4 million additional doses of the Covid-19 antibody cocktail REGEN-COV., as infections surge due to the fast-spreading Delta variant.

29

Roche and NovoCure Announce Partnership for Pancreatic Cancer

Pancreatic cancer has the lowest survival rate of the most common cancers as less than 10 percent of patients survive longer than five years, largely due to most cases being diagnosed at a late stage. A collaboration between NovoCure and Roche hopes to improve those odds.